Cantor Fitzgerald, L. P. Astrazeneca PLC Transaction History
Cantor Fitzgerald, L. P.
- $1.04 Billion
- Q3 2024
A detailed history of Cantor Fitzgerald, L. P. transactions in Astrazeneca PLC stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 148,226 shares of AZN stock, worth $9.94 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
148,226
Previous 14,524
920.56%
Holding current value
$9.94 Million
Previous $1.13 Million
920.23%
% of portfolio
1.11%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.22 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.81 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...